2002 – GenoLogics founded
2003 – Initiates development of LIMS specifically for biological research
2004 – Releases first product for proteomics market
2005 – Expands sales team into Europe
2005 – Secures Series A venture capital financing
2006 – Secures Series B venture capital financing
2007 – Launches LIMS product for genomics market
2007 – Works with Affymetrix to achieve GeneChip-Compatible® status
2008 – Signs largest deal in company’s history with a top tier pharma company
2008 – Illumina selects GenoLogics as its ‘Preferred NGS LIMS Partner’
2008 – Secures Series C venture capital financing
2009 – Enters next-generation sequencing (NGS) market
2009 – Partners with Applied Biosystems to support SOLiD™ sequencing platform
2009 – Installs first LIMS for NGS in major sequencing center
2011 – GenoLogics and Illumina sign co-selling agreement for NGS LIMS
2011 – General release of APIs for genomics customers
2011 – Launches first preconfigured product for Illumina NGS
2011 – GenoLogics raises $8M in strategic financing round